Improvement in cognitive decline after indirect bypass surgery in adult moyamoya disease: implication of
Bypass surgery
Cognitive dysfunction
Moyamoya disease
Positron emission tomography
Reperfusion
Journal
Annals of nuclear medicine
ISSN: 1864-6433
Titre abrégé: Ann Nucl Med
Pays: Japan
ID NLM: 8913398
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
21
02
2020
accepted:
26
04
2020
pubmed:
8
5
2020
medline:
28
5
2021
entrez:
8
5
2020
Statut:
ppublish
Résumé
To investigate the characteristics of patients with moyamoya disease (MMD) who show improvement in their cognitive decline after bypass surgery by analyzing the hemodynamic and metabolic parameters of We retrospectively analyzed adult patients with MMD who were evaluated with PET and cognitive tests before and approximately one year after indirect bypass surgery. The PET parameters of the left Rolandic area were compared between patients who did and did not show improvement in their cognitive decline. Of the 19 patients analyzed, fourteen (74%) showed improvement in either the verbal or performance intelligence quotient (VIQ or PIQ). Three out of four patients with perioperative infarction experienced significant cognitive decline. The preoperative oxygen extraction fraction (OEF) was significantly higher in patients who showed improvement in their cognitive decline in terms of the PIQ than in those patients who did not (P = 0.03). The postoperative increase in the cerebral metabolic rate of oxygen (CMRO Adult patients with MMD might show improvement in their cognitive decline after successful indirect bypass surgery if they have a severely increased regional OEF before the surgery and an increased regional CMRO URL: https://www.umin.ac.jp/ctr/. Unique identifier: UMIN000027949.
Identifiants
pubmed: 32378149
doi: 10.1007/s12149-020-01473-8
pii: 10.1007/s12149-020-01473-8
doi:
Substances chimiques
Oxygen Radioisotopes
0
Oxygen-15
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
467-475Subventions
Organisme : Japan Society for the Promotion of Science
ID : 26305031
Références
Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056–66.
doi: 10.1016/S1474-4422(08)70240-0
Piao R, Oku N, Kitagawa K, Imaizumi M, Matsushita K, Yoshikawa T, et al. Cerebral hemodynamics and metabolism in adult moyamoya disease: comparison of angiographic collateral circulation. Ann Nucl Med. 2004;18(2):115.
doi: 10.1007/BF02985101
Weinberg DG, Rahme RJ, Aoun SG, Batjer HH, Bendok BR. Moyamoya disease: functional and neurocognitive outcomes in the pediatric and adult populations. Neurosurg Focus. 2011;30(6):E21.
doi: 10.3171/2011.3.FOCUS1150
Festa JR, Schwarz LR, Pliskin N, Cullum CM, Lacritz L, Charbel FT, et al. Neurocognitive dysfunction in adult moyamoya disease. J Neurol. 2010;257(5):806–15.
doi: 10.1007/s00415-009-5424-8
Kazumata K, Tha KK, Narita H, Kusumi I, Shichinohe H, Ito M, et al. Chronic ischemia alters brain microstructural integrity and cognitive performance in adult moyamoya disease. Stroke. 2015;46(2):354–60.
doi: 10.1161/STROKEAHA.114.007407
Hara S, Hori M, Murata S, Ueda R, Tanaka Y, Inaji M, et al. Microstructural damage in normal-appearing brain parenchyma and neurocognitive dysfunction in adult moyamoya disease. Stroke. 2018;49:2504–7.
doi: 10.1161/STROKEAHA.118.022367
Hosoda C, Nariai T, Ishiwata K, Ishii K, Matsushima Y, Ohno K. Correlation between focal brain metabolism and higher brain function in patients with Moyamoya disease. Int J Stroke. 2010;5(5):367–73.
doi: 10.1111/j.1747-4949.2010.00461.x
Zeifert PD, Karzmark P, Bell-Stephens TE, Steinberg GK, Dorfman LJ. Neurocognitive performance after cerebral revascularization in adult moyamoya disease. Stroke. 2017;48(6):1514–7.
doi: 10.1161/STROKEAHA.116.016028
Lee JY, Phi JH, Wang KC, Cho BK, Shin MS, Kim SK. Neurocognitive profiles of children with moyamoya disease before and after surgical intervention. Cerebrovasc Dis. 2011;31(3):230–7.
doi: 10.1159/000321901
Wityk RJ, Hillis A, Beauchamp N, Barker PB, Rigamonti D. Perfusion-weighted magnetic resonance imaging in adult moyamoya syndrome: characteristic patterns and change after surgical intervention: case report. Neurosurgery. 2002;51(6):1499–506.
doi: 10.1097/00006123-200212000-00023
Kazumata K, Tha KK, Tokairin K, Ito M, Uchino H, Kawabori M, et al. Brain structure, connectivity, and cognitive changes following revascularization surgery in adult moyamoya disease. Neurosurgery. 2019
Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo) 2012;52(5):245–66.
Matsushima Y, Fukai N, Tanaka K, Tsuruoka S, Inaba Y, Aoyagi M, et al. A new surgical treatment of moyamoya disease in children: a preliminary report. Surg Neurol. 1981;15(4):313–20.
doi: 10.1016/S0090-3019(81)80017-1
Aoyagi M, Tanaka Y, Tamura K, Maehara T, Nariai T, Ohno K. Vasculrrized flap with multiple small dural opening in patients with Moyamoya disease with hemodynamic impariments in the posterior circulation. Video J Neurosurg. 2007;15(4).
Nariai T. Treatment of moyamoya disease using indirect bypass surgery. In: Saito N, editor. Prime neurosurgery 2. Miwa: Cerebral Ischemia; 2017. p. 81–87.
Nariai T, Suzuki R, Matsushima Y, Ichimura K, Hirakawa K, Ishii K, et al. Surgically induced angiogenesis to compensate for hemodynamic cerebral ischemia. Stroke. 1994;25(5):1014–21.
doi: 10.1161/01.STR.25.5.1014
Hara S, Tanaka Y, Ueda Y, Hayashi S, Inaji M, Ishiwata K, et al. Noninvasive evaluation of CBF and perfusion delay of moyamoya disease using arterial spin-labeling MRI with multiple postlabeling delays: comparison with 15O-gas PET and DSC-MRI. AJNR Am J Neuroradiol. 2017;38(4):696–702.
doi: 10.3174/ajnr.A5068
Ishii Y, Tanaka Y, Momose T, Yamashina M, Sato A, Wakabayashi S, et al. Chronologic evaluation of cerebral hemodynamics by dynamic susceptibility contrast magnetic resonance imaging after indirect bypass surgery for moyamoya disease. World Neurosurg. 2017;108:427–35.
doi: 10.1016/j.wneu.2017.09.001
Hosoda C, Nariai T, Kawasaki K, Ishiwata K, Ishii K, Inaji M, et al. Altered correlation between intelligence quotient and PET measured cerebral metabolism induced by surgical revascularization in patients with Moyamoya disease, In: Abstracts of the 13th Annual Meeting of the Organization for Human Brain Mapping (2007). Neuroimage. 2007;36(Supplement 1):e1.
Fujita K, Maekawa H, Dairoku H, Yamanaka K. Assessment cases and clinical researches using Japanese version of WAIS-III: Nihon Bunka Kagakusha; 2011. iv, 278 pp.
Dairoku H. Secular change in: Assesment case series using WISC-III: theory and practice. Kazuhiro F, Kazuhiko U, Hisao M, Toshiyuki I, Hitoshi D, editors: Nihon Bunka Kagakusya; 2005. v, 362 pp.
Senda M, Buxton RB, Alpert NM, Correia JA, Mackay BC, Weise SB, et al. The 15O steady-state method: correction for variation in arterial concentration. J Cereb Blood Flow Metab. 1988;8(5):681–90.
doi: 10.1038/jcbfm.1988.115
Sadato N, Yonekura Y, Senda M, Iwasaki Y, Matoba N, Tamaki N, et al. PET and the autoradiographic method with continuous inhalation of oxygen-15-gas: theoretical analysis and comparison with conventional steady-state methods. J Nucl Med. 1993;34(10):1672–80.
pubmed: 8410280
Iida H, Kanno I, Miura S, Murakami M, Takahashi K, Uemura K. Error analysis of a quantitative cerebral blood flow measurement using H2(15)O autoradiography and positron emission tomography, with respect to the dispersion of the input function. J Cereb Blood Flow Metab. 1986;6:536–45.
doi: 10.1038/jcbfm.1986.99
Lammertsma AA, Jones T. Correction for the presence of intravascular oxygen-15 in the steady-state technique for measuring regional oxygen extraction ratio in the brain: 1. Description of the method. J Cereb Blood Flow Metab. 1983;3(4):416–24.
doi: 10.1038/jcbfm.1983.67
Mintun MA, Raichle ME, Martin WR, Herscovitch P. Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography. J Nucl Med. 1984;25(2):177–87.
pubmed: 6610032
Nariai T, Matsushima Y, Imae S, Tanaka Y, Ishii K, Senda M, et al. Severe haemodynamic stress in selected subtypes of patients with moyamoya disease: a positron emission tomography study. J Neurol Neurosurg Psychiatry. 2005;76(5):663–9.
doi: 10.1136/jnnp.2003.025049
Tanaka Y, Nariai T, Nagaoka T, Akimoto H, Ishiwata K, Ishii K, et al. Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging–comparison with positron emission tomography. J Cereb Blood Flow Metab. 2006;26(2):291–300.
doi: 10.1038/sj.jcbfm.9600187
Baek HJ, Chung SY, Park MS, Kim SM, Park KS, Son HU. Preliminary study of neurocognitive dysfunction in adult moyamoya disease and improvement after superficial temporal artery-middle cerebral artery bypass. J Korean Neurosurg Soc. 2014;56(3):188–93.
doi: 10.3340/jkns.2014.56.3.188
Yanagihara W, Chida K, Kobayashi M, Kubo Y, Yoshida K, Terasaki K, et al. Impact of cerebral blood flow changes due to arterial bypass surgery on cognitive function in adult patients with symptomatic ischemic moyamoya disease. J Neurosurg. 2018:1–9.
Karzmark P, Zeifert PD, Bell-Stephens TE, Steinberg GK, Dorfman LJ. Neurocognitive impairment in adults with moyamoya disease without stroke. Neurosurgery. 2012;70(3):634–8.
doi: 10.1227/NEU.0b013e3182320d1a
Karzmark P, Zeifert PD, Tan S, Dorfman LJ, Bell-Stephens TE, Steinberg GK. Effect of moyamoya disease on neuropsychological functioning in adults. Neurosurgery. 2008;62(5):1048–51.
doi: 10.1227/01.neu.0000325866.29634.4c
Calviere L, Yan Kai G, Catalaa I, Marlats F, Bonneville F, Larrue V. Executive dysfunction in adults with moyamoya disease is associated with increased diffusion in frontal white matter. J Neurol Neurosurg Psychiatry. 2012;83(6):591–3.
doi: 10.1136/jnnp-2011-301388
Kazumata K, Tha KK, Uchino H, Ito M, Nakayama N, Abumiya T. Mapping altered brain connectivity and its clinical associations in adult moyamoya disease: a resting-state functional MRI study. PLoS ONE. 2017;12(8):e0182759.
doi: 10.1371/journal.pone.0182759
Powers WJ. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol. 1991;29(3):231–40.
doi: 10.1002/ana.410290302
Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol. 2009;71(4):442–7.
doi: 10.1016/j.surneu.2008.02.031
Kazumata K, Tha KK, Uchino H, Shiga T, Shichinohe H, Ito M, et al. Topographic changes in cerebral blood flow and reduced white matter integrity in the first 2 weeks following revascularization surgery in adult moyamoya disease. J Neurosurg. 2017;127(2):260–9.
doi: 10.3171/2016.6.JNS16653
Nanba T, Ogasawara K, Nishimoto H, Fujiwara S, Kuroda H, Sasaki M, et al. Postoperative cerebral white matter damage associated with cerebral hyperperfusion and cognitive impairment after carotid endarterectomy: a diffusion tensor magnetic resonance imaging study. Cerebrovasc Dis. 2012;34(5–6):358–67.
doi: 10.1159/000343505
Leblanc R, Tyler JL, Mohr G, Meyer E, Diksic M, Yamamoto L, et al. Hemodynamic and metabolic effects of cerebral revascularization. J Neurosurg. 1987;66(4):529–35.
doi: 10.3171/jns.1987.66.4.0529
Hara S, Hori M, Ueda R, Hayashi S, Inaji M, Tanaka Y, et al. Unraveling specific brain microstructural damage in moyamoya disease using diffusion magnetic resonance imaging and positron emission tomography. J Stroke Cerebrovasc Dis. 2019;28(4):1113–25.
doi: 10.1016/j.jstrokecerebrovasdis.2018.12.038